146 related articles for article (PubMed ID: 11084950)
41. Monthly Oral Ibandronate Reduces Bone Loss in Korean Women With Rheumatoid Arthritis and Osteopenia Receiving Long-term Glucocorticoids: A 48-week Double-blinded Randomized Placebo-controlled Investigator-initiated Trial.
Shin K; Park SH; Park W; Baek HJ; Lee YJ; Kang SW; Choe JY; Yoo WH; Park YB; Song JS; Lee SG; Yoo B; Yoo DH; Song YW
Clin Ther; 2017 Feb; 39(2):268-278.e2. PubMed ID: 28161119
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
Rossini M; Viapiana O; Vitiello M; Malavolta N; La Montagna G; Maddali Bongi S; Di Munno O; Nuti R; Manzini CU; Ferri C; Bogliolo L; Mathieu A; Cantatore F; Del Puente A; Muratore M; Grassi W; Frediani B; Saviola G; Delvino P; Mirone L; Ferraccioli G; Tripi G; Piazza I; Gatti D
Reumatismo; 2017 May; 69(1):30-39. PubMed ID: 28535619
[TBL] [Abstract][Full Text] [Related]
43. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
Benucci M; Dolenti S; Saviola G; Manfredi M
Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926
[TBL] [Abstract][Full Text] [Related]
44. The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials.
Blavnsfeldt AG; de Thurah A; Thomsen MD; Tarp S; Langdahl B; Hauge EM
Bone; 2018 Sep; 114():172-180. PubMed ID: 29913256
[TBL] [Abstract][Full Text] [Related]
45. [Secondary osteoporosis. A review of recent evidence focusing on glucocorticoid-induced osteoporosis and osteoporosis associated with rheumatoid arthritis].
Suzuki Y
Clin Calcium; 2007 Jan; 17(1):104-7. PubMed ID: 17211102
[TBL] [Abstract][Full Text] [Related]
46. An update on glucocorticoid-induced osteoporosis.
Lane NE
Rheum Dis Clin North Am; 2001 Feb; 27(1):235-53. PubMed ID: 11285998
[TBL] [Abstract][Full Text] [Related]
47. Strategies for the prevention and treatment of osteoporosis in patients with rheumatoid arthritis.
Phillips K; Aliprantis A; Coblyn J
Drugs Aging; 2006; 23(10):773-9. PubMed ID: 17067181
[TBL] [Abstract][Full Text] [Related]
48. Loss of cortical bone from the metacarpal diaphysis in patients with rheumatoid arthritis: independent effects of systemic inflammation and glucocorticoids.
Roldán JF; Del Rincón I; Escalante A
J Rheumatol; 2006 Mar; 33(3):508-16. PubMed ID: 16511920
[TBL] [Abstract][Full Text] [Related]
49. Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes.
Boonen S; Haentjens P; Vandenput L; Vanderschueren D
J Intern Med; 2004 Jan; 255(1):1-12. PubMed ID: 14687233
[TBL] [Abstract][Full Text] [Related]
50. Osteoporosis management.
Rozenberg S; Vandromme J; Ayata NB; Filippidis M; Kroll M
Int J Fertil Womens Med; 1999; 44(5):241-9. PubMed ID: 10569453
[TBL] [Abstract][Full Text] [Related]
51. Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial.
Tamechika SY; Sasaki K; Hayami Y; Ohmura SI; Maeda S; Iwagaitsu S; Naniwa T
Arch Osteoporos; 2018 Jun; 13(1):67. PubMed ID: 29904824
[TBL] [Abstract][Full Text] [Related]
52. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
[TBL] [Abstract][Full Text] [Related]
53. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
Yosipovitch G; Hoon TS; Leok GC
Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological interventions for post-menopausal osteoporosis: an evidence-based approach.
Compston JE
Rheumatology (Oxford); 2000 Dec; 39(12):1309-12. PubMed ID: 11136870
[No Abstract] [Full Text] [Related]
55. Bone disease in asthma.
Walsh LJ; Tattersfield AE
Br J Hosp Med; 1997 Apr 16-May 6; 57(8):390-3. PubMed ID: 9296791
[No Abstract] [Full Text] [Related]
56. The effect of vitamin D on bone and osteoporosis.
Lips P; van Schoor NM
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):585-91. PubMed ID: 21872800
[TBL] [Abstract][Full Text] [Related]
57. Characterization of multinucleated giant cells in synovium and subchondral bone in knee osteoarthritis and rheumatoid arthritis.
Prieto-Potin I; Largo R; Roman-Blas JA; Herrero-Beaumont G; Walsh DA
BMC Musculoskelet Disord; 2015 Aug; 16():226. PubMed ID: 26311062
[TBL] [Abstract][Full Text] [Related]
58. [New spine and non-spine fractures in 871 women/year treated with oral pamidronate plus calcium and vitamin D supplements].
Man Z; Otero AB
Medicina (B Aires); 1997; 57 Suppl 1():32-6. PubMed ID: 9567352
[TBL] [Abstract][Full Text] [Related]
59. Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats.
Wezeman FH; Juknelis D; Himes R; Callaci JJ
Bone; 2007 Oct; 41(4):639-45. PubMed ID: 17643361
[TBL] [Abstract][Full Text] [Related]
60. [Prospective cohort studies of incident fractures in patients with rheumatoid arthritis].
Furuya T; Kotake S; Nanke Y; Yamanaka H; Kamatani N
Nihon Rinsho; 2007 Nov; 65 Suppl 9():125-9. PubMed ID: 18161095
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
